
CLEAR CSCC is evaluating whether low-dose intralesional cemiplimab is noninferior to primary surgery, potentially offering a tissue-sparing alternative to standard surgical management.
Marie Bosslett is the assistant editor of Dermatology Times® and joined the MJH Life Sciences team in October 2024. She attended Loyola University Maryland in Baltimore and earned a Bachelor of Arts in Communication with minors in marketing and writing. When she’s not writing, Marie enjoys going to concerts, reading on the beach, and spending time with friends and family.

CLEAR CSCC is evaluating whether low-dose intralesional cemiplimab is noninferior to primary surgery, potentially offering a tissue-sparing alternative to standard surgical management.

Brian Berman, MD, PhD, explains actinic keratosis-to-SCC risk and newer PDT/field therapies that improve clearance with less pain.

Ruiz Dasilva emphasized case-based strategies for managing complex inflammatory dermatoses, highlighted chronic pruritus as an urgent unmet need, and called for more standardized designs for atopic dermatitis trials.

Terrence Keaney, MD, and Dawn Merritt, DO, discuss AI workflows and smart practice systems—plus how a dermatology niche drives referrals and growth.

James Del Rosso, DO, shares rapid-fire insights on mentorship, HS advances, contact dermatitis triggers, and teen skin care marketing concerns.

Catch up on coverage from the final day of Winter Clinical Miami 2026.

Rapid-fire WCM tips included off-label treatment strategies, AI-driven practice management tools, and patient optimization methods.

Real-world data shows Medicare plaque psoriasis patients stay on Sun Pharma’s IL-23 tildrakizumab longer than other systemic therapies.

At Winter Clinical Miami, Lisa Swanson, MD, FAAD, shared practical, prior authorization–free treatment strategies while calling for expanded therapeutic options and earlier research inclusion for children under 12.

At Winter Clinical Miami 2026, Lewitt and Goldenberg share contract, workflow, and ethical industry tips every early career derm needs to thrive.

Nicholas Brownstone, MD, showcased multidisciplinary collaboration and educational podcast initiatives aimed at supporting both dermatology trainees and patients.

Catch up on coverage from the second day of Winter Clinical Miami 2026.

Harrison Nguyen, MD, MBA, MPH, FAAD, shares early career billing, coding, and mentorship tips for dermatologists at Winter Clinical Miami 2026.

A Winter Clinical Miami poster highlights intralesional cemiplimab for early CSCC, showing rapid responses and positive safety versus surgery.

At Winter Clinical Miami 2026, Linda Stein Gold, MD, FAAD, shared acne and rosacea tips and previewed psoriasis oral advances like icotrokinra.

At Winter Clinical Miami 2026, April Armstrong, MD, MPH, spotlights new pediatric topicals and JAK safety insights, plus targeted options for head-and-neck atopic dermatitis.

A poster presented at Winter Clinical Miami 2026 shows tildrakizumab is often preferred for older patients with plaque psoriasis and medically complex comorbidities.

Catch up on coverage from the first day of Winter Clinical Miami 2026.

Mark Lebwohl, MD, shares his Winter Clinical Miami 2026 highlights, including oral psoriasis peptides, atopic dermatitis advances, GLP-1 combos, and more.

Winter Clinical Miami 2026 speakers share buy-and-bill and real estate tactics for dermatologists to boost revenue and protect cash flow.

Gary Goldenberg, MD shares branding, pricing, and tech tips to grow a profitable aesthetic dermatology practice at Winter Clinical Miami 2026.

At Winter Clinical Miami 2026, Mona Shahriari, MD, revealed a comprehensive roadmap to launch and scale dermatology clinical trials.

As Winter Clinical kicks off in Aventura, Florida, scroll through and find some faces familiar to Dermatology Times who are presenting at the meeting.

Winter Clinical Miami 2026 kicks off today with the latest dermatology updates—let us know if you're attending and stay tuned for live coverage, pearls, and interviews.

Review our content from the month of February that recognizes patients and clinicians with skin of color.

Dermatology Times is looking back on the top stories in dermatology from the month of February.

Learn more about the in-depth topics covered in the February 2026 print issue of Dermatology Times.

The FDA has assigned a Prescription Drug User Fee Act target action date of December 12, 2026.

Revance and Teoxane’s RHA Dynamic Volume earns FDA approval for midface lift, delivering natural movement and lasting cheek contour in supporting clinical trials.

Joni Jefferson, DO, spotlights skin of color dermatology, safer lasers, mentorship, and the future of aesthetic medicine during Black History Month.